0
Article ? AI-assigned paper type based on the abstract. Classification may not be perfect — flag errors using the feedback button. Tier 2 ? Original research — experimental, observational, or case-control study. Direct primary evidence. Gut & Microbiome Human Health Effects Remediation Sign in to save

Degradation of PET microplastic particles to monomers in human serum by designer enzymes

2023 Score: 40 ? 0–100 AI score estimating relevance to the microplastics field. Papers below 30 are filtered from public browse.
Ximena Lopez‐Lorenzo, Ximena Lopez‐Lorenzo, Ximena Lopez‐Lorenzo, Ximena Lopez‐Lorenzo, Ximena Lopez‐Lorenzo, David Hueting, David Hueting, David Hueting, David Hueting, David Hueting, David Hueting, David Hueting, David Hueting, David Hueting, David Hueting, Eliott Bosshard, Eliott Bosshard, Eliott Bosshard, Eliott Bosshard, Eliott Bosshard, Per‐Olof Syrén, Per‐Olof Syrén Per‐Olof Syrén Per‐Olof Syrén Per‐Olof Syrén Per‐Olof Syrén Per‐Olof Syrén, Per‐Olof Syrén, Per‐Olof Syrén, Per‐Olof Syrén Per‐Olof Syrén

Summary

Researchers demonstrated that engineered PETase enzymes can depolymerize PET microplastic particles into the non-toxic monomer terephthalic acid directly in human serum at body temperature, offering a potential strategy for clearing PET microplastics from blood and other bodily fluids.

Polymers
Models
Study Type In vitro

<title>Abstract</title> Due to prolonged exposure, microplastic particles are found in human blood and other bodily fluids. Despite a lack of toxicity studies regarding microplastics, harmful effects for humans seem plausible and cannot be excluded. As small plastic particles readily translocate from the gut to body fluids, enzyme-based treatment of serum could constitute a promising avenue to clear synthetic polymers and their responding oligomers by degradation into monomers. Still, the activity of plastic degrading enzymes in serum remains unknown. Here we report how engineered PETases can depolymerize microplastic-like particles of the commodity polymer polyethylene terephthalate (PET) into its non-toxic monomer terephthalic acid (TPA) in human serum at 37°C. By developing an efficient method to depolymerize microplastics <italic>in vitro</italic> , our work takes a step closer to find a solution to the problem that microplastics in the bloodstream may pose in the future.

Sign in to start a discussion.

Share this paper